Second Generation" Drug-Eluting Stents Implantation followed by Six versus Twelve-Month - Dual Antiplatelet Therapy

Trial Profile

Second Generation" Drug-Eluting Stents Implantation followed by Six versus Twelve-Month - Dual Antiplatelet Therapy

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2016

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Coronary artery disease; Coronary stent thrombosis
  • Focus Therapeutic Use
  • Acronyms SECURITY
  • Most Recent Events

    • 03 Feb 2014 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 13 Aug 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
    • 29 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top